Mark A. Lemmon

35.1k citations

171 papers · 27.2k · 3 hit papers · h-index 79

Impact in

Cell Biology top 0.1%
- Cellular transport and secretion
Oncology top 0.5%
- HER2/EGFR in Cancer Research

Papers in

Oncology 38
- HER2/EGFR in Cancer Research 38
Cell Biology 18
- Cellular transport and secretion 15

Co-authors: Joseph Schlessinger (29 shared papers)Kathryn M. Ferguson (25 shared papers)Donald M. Engelman (12 shared papers)Jeannine M. Mendrola (10 shared papers)Irit Lax (7 shared papers)Mitchell B. Berger (4 shared papers)Paul B. Sigler (3 shared papers)Daryl E. Klein (10 shared papers)
Journals: Journal of Biological Chemistry (18 papers)Cell (13 papers)Proceedings of the National Academy of Sciences (12 papers)Biochemical Journal (9 papers)The EMBO Journal (9 papers)
Partner nations: United States United Kingdom Germany

In The Last Decade

Mark A. Lemmon

169 papers receiving 26.5k citations

Mark A. Lemmon's Hit Papers

align trajectories log scale

Cell Signaling by Receptor Tyrosine Kinases 2010 · 5.0k citations

What are hit papers?

Paper score: A paper's citations measured against the top-1% bar of its own field and year: the square root of citations ÷ bar, so 1 means right at the bar and 2 means four times its citations. The bar blends the citation counts that enter the top 1% of the paper's subfields in its year (weighted 89.5%), of those subfields over all years (0.5%) and of its year across all fields (10%); a subfield and year with fewer than 400 papers takes its year's bar. Papers from 2026 are not scored yet: in an unfinished year, when a paper appeared matters more than how it is cited.

Hit paper: A paper cited at least 1.5× the top-1% bar of its field and year: a paper score of at least √1.5.

2010 Cell
2008 Nature Reviews Molecular Cell Biology
2000 Biochemical Journal

Peers

Countries citing papers authored by Mark A. Lemmon

Since Specialization

Citations

This map shows the geographic impact of Mark A. Lemmon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Lemmon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Lemmon more than expected).

Fields of papers citing papers by Mark A. Lemmon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Lemmon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Lemmon. The network helps show where Mark A. Lemmon may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark A. Lemmon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark A. Lemmon Line = papers co-authored together Mark A. Lemmon links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 171 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Cell Signaling by Receptor Tyrosine Kinases Cell ·Mark A. Lemmon, Joseph Schlessinger Hit paper breakdown →	2010	5030
2	Membrane recognition by phospholipid-binding domains Nature Reviews Molecular Cell Biology ·Mark A. Lemmon Hit paper breakdown →	2008	1234
3	An Open-and-Shut Case? Recent Insights into the Activation of EGF/ErbB Receptors Molecular Cell ·Antony Wilks Burgess, Hyun‐Soo Cho, Charles W. Eigenbrot, Kathryn M. Ferguson, Thomas Garrett, Daniel J. Leahy, Mark A. Lemmon, Mark X. Sliwkowski	2003	720
4	EGF Activates Its Receptor by Removing Interactions that Autoinhibit Ectodomain Dimerization Molecular Cell ·Kathryn M. Ferguson, Mitchell B. Berger, Jeannine M. Mendrola, Hyun-Soo Cho, Daniel J. Leahy, Mark A. Lemmon	2003	631
5	Signal-dependent membrane targeting by pleckstrin homology (PH) domains Biochemical Journal ·Mark A. Lemmon, Kathryn M. Ferguson Hit paper breakdown →	2000	618
6	Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation Cell ·Taly R. Spivak-Kroizman, Mark A. Lemmon, Ivan Đikić, John Edward Ladbury, Dalia Pinchasi, Jiaoti Huang, Michael Jaye, Gregg Crumley	1994	586
7	Structure of the high affinity complex of inositol trisphosphate with a phospholipase C pleckstrin homology domain Cell ·Kathryn M. Ferguson, Mark A. Lemmon, Joseph Schlessinger, Paul B. Sigler	1995	524
8	Activation of phospholipase Cγ by PI 3‐kinase‐induced PH domain‐mediated membrane targeting The EMBO Journal ·Marco Falasca, Susan K. Logan, Mark A. Lemmon, Joseph Schlessinger +2 others	1998	492
9	Specific and high-affinity binding of inositol phosphates to an isolated pleckstrin homology domain. Proceedings of the National Academy of Sciences ·Mark A. Lemmon, K M Ferguson, Ronan O’Brien, Paul B. Sigler, Joseph Schlessinger	1995	489
10	Phosphoinositide Recognition Domains Traffic ·Mark A. Lemmon	2003	486
11	Sequence specificity in the dimerization of transmembrane .alpha.-helixes Biochemistry ·Mark A. Lemmon, John M. Flanagan, Herbert Treutlein, Jian Zhang, Donald M. Engelman	1992	456
12	Glycophorin A dimerization is driven by specific interactions between transmembrane alpha-helices. Journal of Biological Chemistry ·Mark A. Lemmon, John M. Flanagan, John Francis Hunt, Brian D. Adair, Barbara J. Bormann, Christopher E. Dempsey, Donald M. Engelman	1992	427
13	PH Domains: Diverse Sequences with a Common Fold Recruit Signaling Molecules to the Cell Surface Cell ·Mark A. Lemmon, Kathryn M. Ferguson, Joseph Schlessinger	1996	422
14	Regulation of growth factor activation by proteoglycans: What is the role of the low affinity receptors? Cell ·Joseph Schlessinger, Irit Lax, Mark A. Lemmon	1995	419
15	Regulation of signal transduction and signal diversity by receptor oligomerization Trends in Biochemical Sciences ·Mark A. Lemmon, Joseph Schlessinger	1994	404
16	ErbB3/HER3 intracellular domain is competent to bind ATP and catalyze autophosphorylation Proceedings of the National Academy of Sciences ·Fumin Shi, Shannon Telesco, Yingting Liu, Ravi Radhakrishnan, Mark A. Lemmon	2010	393
17	Specificity and Promiscuity in Phosphoinositide Binding by Pleckstrin Homology Domains Journal of Biological Chemistry ·Jennifer M. Kavran, Daryl E. Klein, Anthony J. Lee, Marco Falasca, SJ Isakoff, Edward Y. Skolnik, Mark A. Lemmon	1998	385
18	Erlotinib binds both inactive and active conformations of the EGFR tyrosine kinase domain Biochemical Journal ·Jin H. Park, Yingting Liu, Mark A. Lemmon, Ravi Radhakrishnan	2012	334
19	ALK Mutations Confer Differential Oncogenic Activation and Sensitivity to ALK Inhibition Therapy in Neuroblastoma Cancer Cell ·Scott C. Bresler, Daniel A. Weiser, Peter J. Huwe, Jin H. Park, Kateryna Krytska, Hannah T. Ryles, Marci Laudenslager, Eric F. Rappaport	2014	310
20	Two EGF molecules contribute additively to stabilization of the EGFR dimer The EMBO Journal ·Mark A. Lemmon, John Edward Ladbury, Min Zhou, Donald M. Engelman, Joseph Schlessinger +3 others	1997	305

About Mark A. Lemmon

Mark A. Lemmon is a scholar working on Oncology, Cell Biology, Molecular Biology, Neurology and Pulmonary and Respiratory Medicine, having authored 171 papers that have together received 27.2k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (38 papers), Protein Kinase Regulation and GTPase Signaling (26 papers), Cellular transport and secretion (15 papers), Lipid Membrane Structure and Behavior (8 papers), Lung Cancer Treatments and Mutations (6 papers), Neuroblastoma Research and Treatments (6 papers), Receptor Mechanisms and Signaling (4 papers) and Protein Structure and Dynamics (4 papers). The work is most often cited by research in Cell Biology (2.4k citations), Oncology (3.3k citations), Molecular Biology (7.9k citations), Immunology and Allergy (202 citations) and Neurology (537 citations). Mark A. Lemmon has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Joseph Schlessinger, Kathryn M. Ferguson, Donald M. Engelman, Jeannine M. Mendrola, Irit Lax, Mitchell B. Berger, Paul B. Sigler, Daryl E. Klein, Daniel J. Leahy and Ravi Radhakrishnan. Their work appears in journals such as Journal of Biological Chemistry, Cell, Proceedings of the National Academy of Sciences, Biochemical Journal and The EMBO Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Mark A. Lemmon

Impact in

Papers in i

In The Last Decade

Mark A. Lemmon

Mark A. Lemmon's Hit Papers

Peers

Countries citing papers authored by Mark A. Lemmon

Fields of papers citing papers by Mark A. Lemmon

All Works

About Mark A. Lemmon

Explore authors with similar magnitude of impact

Papers in